ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion

NCT04744051 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Concussion Syndrome

Interventions

DRUG: 50 Adipose Derived Stem Cell Infusion
DRUG: 150 Adipose Derived Stem Cell Infusion
DRUG: 300 Adipose Derived Stem Cell Infusion
DRUG: Placebo Infusion

Sponsor

American CryoStem Corporation